Open AccessImmune Thrombocytopenic Purpura in Patients with COVID-19
Author(s) -
Sabine Revuz,
N. Vernier,
L Saadi,
J. Campagne,
Sophie Poussing,
F. Maurier
Publication year - 2020
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2020_001751
Subject(s) - medicine , mucocutaneous zone , thrombocytopenic purpura , immune system , covid-19 , antibody , purpura (gastropod) , immunology , immune thrombocytopenia , disease , infectious disease (medical specialty) , ecology , biology
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.